**By-Health’s QiGao Calcium Wins “Product Innovation Award” at FFC 2026 Functional Food Conference, Setting a New Benchmark for Children’s Bone Nutrition**

GuangzhouMay 15, 2026 /PRNewswire/ — Recently, the FFC 2026 Functional Food Conference (hereinafter referred to as the “Conference”) was held in Hangzhou. As an annual industry event, the Conference brought together over 2,000 experts and corporate representatives from both domestic and international backgrounds to discuss scientific innovation and industrial upgrading in the field of health functional foods.


By-Health, a leading brand and benchmark enterprise in China’s dietary supplement (VDS) industry, was invited to attend the Conference and share its latest research and development achievements, drawing significant attention. At the same time, By-Health was honored with the FFC 2026 “Product Innovation Award” for the innovative breakthrough in the formulation of its flagship children’s liquid calcium product—the new generation By-Health Lysine K2 Enhanced Qigao Calcium. With its strong scientific research capabilities, By-Health leads the children’s calcium supplement track, underscoring the brand’s benchmark status and industry recognition in the field of children’s bone nutrition.


Adhering to Evidence-Based Medicine to Provide Scientific Nutritional Support for Children and Adolescents

Currently, By-Health has established a comprehensive R&D cycle from needs identification and formula specialization to clinical validation. Focusing on the nutritional needs of Chinese children and adolescents, and covering dimensions such as bone health, brain power, vision, immunity, and growth potential, the company is committed to transforming evidence-based medical research into scientific product solutions, providing professional, precise, and effective nutritional support for over 300 million children and adolescents in China^.

Efficacy-Level Formula Defines New Standards for Children’s Bone Nutrition

Currently, the children’s calcium market is flooded with products, but issues such as conceptual additions, inflated content claims, and insufficient active ingredients are common. This leaves many parents troubled not only by the feeling that “their children are supplementing in vain” but also concerned about missing critical nutritional windows during their children’s growth stages.

To provide precise and efficient nutritional solutions for children and adolescents, By-Health has taken the lead in integrating a multi-dimensional evidence-based research system throughout the entire product development process, enabling data-driven product innovation. Previously, addressing the growth and development nutritional needs of children and adolescents aged 4-17, By-Health launched the By-Health Qigao Calcium Zinc Vitamin D Vitamin K Oral Liquid in 2025. Each 2 sticks contain 70 micrograms of Vitamin K2, making the brand the first in the industry to advocate for adequate Vitamin K2 intake in adolescents and children, thereby promoting effective calcium deposition.

Furthermore, the By-Health Qigao Calcium Zinc Vitamin D Vitamin K Oral Liquid innovatively applies the brand’s proprietary nano-emulsification technology, overcoming the industry technical challenge of “easy oxidation and degradation of Vitamin D and Vitamin K in oral liquids.” This technology increases the retention rate of nutrients in the product by 25.6%**, preserving the original activity of nutrients for long-term storage, ensuring more stable ingredient states and more efficient human absorption, achieving a breakthrough upgrade in industry technology.

The new generation By-Health Lysine K2 Enhanced Qigao Calcium, which won the “Product Innovation Award,” leads industry innovation with its “dual-effect efficacy formula,” aiming to provide a “noticeable height boost” calcium supplementation experience. While retaining the adequate 70 micrograms of Vitamin K2 per 2 sticks, it adds 500 milligrams of lysine at a clinically effective dose, forming a “growth signal factor + calcium absorption factor” dual-effect combination. Clinical data shows that children aged 6-12 who supplement with 500 milligrams of lysine daily for six consecutive months experience an approximately 93%* greater increase in height compared to the control group. The product contains 8 key bone nutrients, comprehensively covering bone development needs, and has passed over 400 safety tests, offering parents a “visible and verifiable” precise children’s calcium option. As an iterative masterpiece, it not only continues By-Health’s core logic of ensuring key ingredients in children’s bone nutrition products meet “clinically effective doses” but also redefines product standards with “dual effects + empirical evidence,” solidifying the brand’s leading position in this track and earning dual recognition from the industry and consumers.


Multi-Dimensional Empowerment for Adolescent Growth, Strengthening Brand Professional Status

Beyond deep research and product innovation, By-Health is dedicated to bringing professional nutrition into children’s growth scenarios. To this end, By-Health has established a deep partnership with the domestic youth basketball sports event IP “Junior CBA National Challenge,” serving as an official partner to provide professional-level bone nutritional support for young athletes. This collaboration not only brings evidence-based research results to the public and popularizes children’s nutrition knowledge but also reinforces the brand’s professional status in the field of children’s bone nutrition.

In the future, By-Health will increase its investment in scientific research, continue to delve into the field of children’s nutrition research, define growth nutrition solutions with rigorous scientific standards, and persistently provide more scientific, precise, and high-quality nutritional choices for children and adolescents worldwide.

 

Share your love
rocky TT
rocky TT

one world one dream

Articles: 2464
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x